Mayo Clinic

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Mayo Clinic sits in the top decile of US sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count).

2,844 total trials 544 currently recruiting 1816 completed early-phase tilt top decile by trial count

Mayo Clinic: 2,844 sponsored US clinical trials, 544 recruiting.

Mayo Clinic sponsors 2,844 registered US clinical trials on ClinicalTrials.gov, 544 of them currently recruiting, and 1,816 completed. 252 of these trials are in Phase 3-4 (later-stage) and 821 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Healthy, with 36 trials.

Top-decile sponsor footprint

Mayo Clinic ranks in the top decile of sponsors by registered trial count (#2 of 15,751 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

2,844 total, page 42 of 57

COMPLETED Early Phase 1

Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

NCT01719250

COMPLETED

Cough Reflex Sensitivity and Bronchial Hyper-responsiveness

NCT01777867

TERMINATED NA

Cytosponge Protocol IRB 11-006429

NCT01585103

COMPLETED NA

Collaborative Targeted Case Management in Improving Functional Status in Patients With Stage III-IV Cancer

NCT01721343

TERMINATED Phase 2

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Relapsed or Refractory Multiple Myeloma

NCT01646762

COMPLETED Early Phase 1

Auranofin in Treating Patients With Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

NCT01747798

COMPLETED Phase 1

Effect of Vitamin D Supplementation on Endothelial Function in Obese Adolescents

NCT01746264

COMPLETED Phase 4

Modulation of Esophageal Inflammation in Barrett's Esophagus by Omega-3 Fatty Acids

NCT01733147

COMPLETED Phase 1

Amyloid-related Imaging Abnormalities (Microbleeds) in Atypical AD

NCT01723553

COMPLETED NA

Sleep Apnea and Vascular Function

NCT01717339

COMPLETED Phase 1

Influence of Medication Taste on Pediatric Prescribers' Prescribing Habits

NCT01734759

COMPLETED NA

The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery Disease

NCT01771536

COMPLETED

Outcomes of Intrathecal Analgesia in Colorectal Surgery

NCT03411109

COMPLETED NA

Dietary Interventions in Prediabetes

NCT01729078

COMPLETED NA

Prospective Use of Real-time MRI

NCT01644578

COMPLETED NA

Title: "Development and Implementation of Innovative Auditory Training Methods and Verification of These Training Methods"

NCT01737489

COMPLETED Phase 1

Muscle Protein Metabolism in Obesity

NCT01824173

COMPLETED NA

Effects of Aging and Aerobic Exercise Training on Brain Glucose Metabolism

NCT01738568

COMPLETED

Cortical Excitability and Inhibition in MDD

NCT01718730

COMPLETED Early Phase 1

Vaccine Therapy and Resiquimod in Treating Patients With Stage II-IV Melanoma That Has Been Removed By Surgery

NCT01748747

COMPLETED NA

Feasibility of Use of BariCare App in Pre-bariatric Surgery.

NCT01708135

TERMINATED

A Pilot Study to Evaluate the Contribution of the Saphenous Nerve in Ankle Pain of Patients With Degenerative Joint Disease of the Ankle

NCT01716650

TERMINATED Phase 2

Metformin as a Chemoprevention Agent in Non-small Cell Lung Cancer

NCT01717482

COMPLETED NA

Mitochondrial Dysfunction in Diabetes

NCT01724502

COMPLETED NA

Endoscopic Full Thickness Biopsy, Gastric Wall.

NCT01650714

COMPLETED

Handheld Echocardiography in Clinical Practice

NCT01558518

COMPLETED NA

Pilot Study: Combined Molecular Breast Imaging/Ultrasound System for Diagnostic Evaluation of MBI-detected Lesions

NCT01806558

COMPLETED Phase 4

Does Tranexamic Acid Reduce the Need for Blood Transfusions in Patients Undergoing Hip Fracture Surgery?

NCT01714336

COMPLETED NA

A Transplant or Cancer Resilience Intervention

NCT01629069

COMPLETED Phase 3

Weight Loss in Parkinson's Disease and Role of Small Bowel Bacterial Overgrowth

NCT01662791

COMPLETED NA

PGC-1 and Mitochondrial Dysfunction in Diabetes

NCT01724515

COMPLETED

DNA, Blood and Skin Cell Repository for Research on ALS and Related Neurodegenerative Disorders at Mayo Clinic Florida

NCT01699451

TERMINATED NA

Patency of a Prototype Large Plastic Biliary Stent in the Palliation of Malignant Distal Biliary Strictures.

NCT01590394

COMPLETED Phase 1

Viral Therapy in Treating Patient With Refractory Liver Cancer or Advanced Solid Tumors

NCT01628640

COMPLETED Phase 1

Endoscopic Gastric Reduction for Weight Management

NCT01682733

COMPLETED

Cardiopulmonary Exercise Testing in Cirrhotic Patients: a Pilot Study

NCT01658982

COMPLETED Phase 1

Verapamil vs. Sertraline for Vestibular Migraine & Chronic Subjective Dizziness

NCT01669304

COMPLETED Phase 1

A Pilot Study of Xifaxan to Treat Patients With PSC

NCT01695174

COMPLETED

Epigenetics and the Origin of Muscle Insulin Resistance in Humans

NCT01726491

COMPLETED Phase 1

Intestinal Permeability in Response to Treatment in Eosinophilic Esophagitis Patients

NCT01641913

COMPLETED Phase 2

Pasireotide LAR in Severe Polycystic Liver Disease

NCT01670110

COMPLETED Phase 1

Exercise and Low-Dose Rapamycin in Older Adults With CAD:Cardiac Rehabilitation And Rapamycin in Elderly (CARE) Trial

NCT01649960

COMPLETED Phase 3

Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction

NCT01591746

COMPLETED NA

MRS Probe Study of Alcohol

NCT01679444

COMPLETED

Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough

NCT01667042

COMPLETED NA

Dent Disease Mutation Genotyping

NCT01783795

COMPLETED

Confocal Endomicroscopy for GI Neoplasia Study

NCT01515514

COMPLETED Phase 1

ANX-042 Healthy Volunteer Dose Escalation Study

NCT01638104

TERMINATED NA

SCD Use to Prevent Deep Venous Thrombosis (DVT) in Patients With PICC Lines

NCT01670188

TERMINATED Phase 2

Oral Ketamine in the Treatment of Depression and Anxiety in Patients With Cancer

NCT01680172

← Previous Page 42 of 57 Next →

Phase Distribution

PhaseTrial count
Phase 1 435
Phase 2 386
Phase 3 86
Phase 4 166

What is open in the Mayo Clinic pipeline

544 recruiting of 2,844 indexed (19% open); 1,816 completed (64%).

Phase mix: 252 late (III/IV) vs 821 early (I/II) (early-phase heavy).

Top condition: Healthy (36 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial from this sponsor, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.